Silvant Capital Management’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.7M | Buy |
97,003
+6,381
| +7% | +$3.23M | 1.55% | 14 |
|
|
2025
Q4 | $51.3M | Buy |
90,622
+254
| +0.3% | +$135K | 1.73% | 15 |
|
|
2025
Q3 | $40.4M | Buy |
90,368
+3,539
| +4% | +$1.7M | 1.4% | 16 |
|
|
2025
Q2 | $47.2M | Buy |
86,829
+542
| +0.6% | +$283K | 1.78% | 14 |
|
|
2025
Q1 | $42.7M | Buy |
86,287
+252
| +0.3% | +$139K | 1.97% | 13 |
|
|
2024
Q4 | $44.9M | Buy |
86,035
+2,477
| +3% | +$1.29M | 1.86% | 13 |
|
|
2024
Q3 | $41M | Sell |
83,558
-50
| -0.1% | -$23.3K | 1.8% | 13 |
|
|
2024
Q2 | $37.2M | Buy |
83,608
+7,792
| +10% | +$3.1M | 1.65% | 14 |
|
|
2024
Q1 | $30.3M | Buy |
75,816
+400
| +0.5% | +$151K | 1.44% | 17 |
|
|
2023
Q4 | $25.4M | Sell |
75,416
-1,242
| -2% | -$370K | 1.37% | 17 |
|
|
2023
Q3 | $22.4M | Sell |
76,658
-459
| -0.6% | -$143K | 1.35% | 18 |
|
|
2023
Q2 | $26.4M | Buy |
77,117
+1,967
| +3% | +$595K | 1.48% | 15 |
|
|
2023
Q1 | $19.2M | Sell |
75,150
-1,285
| -2% | -$317K | 1.25% | 20 |
|
|
2022
Q4 | $20.3M | Sell |
76,435
-1,991
| -3% | -$485K | 1.44% | 16 |
|
|
2022
Q3 | $14.7M | Buy |
78,426
+68,912
| +724% | +$14.8M | 1% | 20 |
|
|
2022
Q2 | $1.91M | Buy |
9,514
+13
| +0.1% | +$3.05K | 0.46% | 53 |
|
|
2022
Q1 | $2.87M | Sell |
9,501
-114
| -1% | -$33.3K | 0.55% | 47 |
|
|
2021
Q4 | $3.46M | Sell |
9,615
-426
| -4% | -$147K | 0.59% | 42 |
|
|
2021
Q3 | $3.33M | Sell |
10,041
-1,896
| -16% | -$637K | 0.59% | 41 |
|
|
2021
Q2 | $3.66M | Sell |
11,937
-195
| -2% | -$54.7K | 0.58% | 42 |
|
|
2021
Q1 | $2.99M | Sell |
12,132
-348
| -3% | -$87.6K | 0.51% | 51 |
|
|
2020
Q4 | $3.4M | Sell |
12,480
-219
| -2% | -$54.4K | 0.58% | 40 |
|
|
2020
Q3 | $3M | Sell |
12,699
-3,303
| -21% | -$742K | 0.56% | 42 |
|
|
2020
Q2 | $3.04M | Sell |
16,002
-1,026
| -6% | -$184K | 0.55% | 42 |
|
|
2020
Q1 | $2.81M | Sell |
17,028
-315
| -2% | -$57.7K | 0.61% | 45 |
|
|
2019
Q4 | $3.42M | Sell |
17,343
-243
| -1% | -$45.5K | 0.62% | 44 |
|
|
2019
Q3 | $3.17M | Sell |
17,586
-2,238
| -11% | -$387K | 0.63% | 47 |
|
|
2019
Q2 | $3.47M | Sell |
19,824
-1,827
| -8% | -$313K | 0.62% | 49 |
|
|
2019
Q1 | $4.12M | Sell |
21,651
-846
| -4% | -$150K | 0.74% | 35 |
|
|
2018
Q4 | $3.59M | Sell |
22,497
-6,144
| -21% | -$1.04M | 0.72% | 43 |
|
|
2018
Q3 | $5.48M | Sell |
28,641
-4,602
| -14% | -$817K | 0.68% | 49 |
|
|
2018
Q2 | $5.3M | Sell |
33,243
-363
| -1% | -$55.4K | 0.66% | 54 |
|
|
2018
Q1 | $4.62M | Buy |
+33,606
| New | +$4.69M | 0.59% | 67 |
|
Other funds holding ISRG
VCM
VPM
Silvant Capital Management's ISRG Position: Q1 2026 in Review
Silvant Capital Management increased its Intuitive Surgical (ISRG) stake by 7% in Q1 2026, buying an estimated $3.23M and bringing the position to 97,003 shares worth $44.7M. The position accounts for 1.55% of the portfolio, ranked #14.
Silvant Capital Management first reported a position in ISRG in Q1 2018 and has held it in 33 quarters since. The position peaked at $51.3M in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Silvant Capital Management held 97,003 shares of Intuitive Surgical worth $44.7M as of Q1 2026.
- Silvant Capital Management bought 6,381 Intuitive Surgical shares in Q1 2026, an estimated $3.23M.
- Intuitive Surgical made up 1.55% of Silvant Capital Management's portfolio in Q1 2026, its #14 holding.
- Silvant Capital Management first reported a position in Intuitive Surgical in Q1 2018 and has held it in 33 quarters since.
- Silvant Capital Management's Intuitive Surgical position peaked at $51.3M in Q4 2025.
- 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.